A CRISPR-based SARS-CoV-2 diagnostic assay that is robust against viral evolution and RNA editing
Ooi, K. H.; Tay, J. W. D.; Teo, S. Y.; Liu, M. M.; Kaewsapsak, P.; Jin, S.; Gao, Y.-G.; Tan, M. H.
Show abstract
Extensive testing is essential to break the transmission of the new coronavirus SARS-CoV-2, which causes the ongoing COVID-19 pandemic. Recently, CRISPR-based diagnostics have emerged as attractive alternatives to quantitative real-time PCR due to their faster turnaround time and their potential to be used in point-of-care testing scenarios. However, existing CRISPR-based assays for COVID-19 have not considered viral genome mutations and RNA editing in human cells. Here, we present the VaNGuard (Variant Nucleotide Guard) test that is not only specific and sensitive for SARS-CoV-2, but can also detect the virus when its genome or transcriptome has evolved or has been edited by deaminases in infected human cells. We show that an engineered AsCas12a enzyme is more tolerant of mismatches than wildtype LbCas12a and that multiplexed Cas12a targeting can overcome the presence of single nucleotide variations. Our assay can be completed in 30 minutes with a dipstick for a rapid point-of-care test.Competing Interest StatementThe authors have declared no competing interest.View Full Text
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Highly Specific Enrichment of Rare Nucleic Acids using Thermus Thermophilus Argonaute with Applications in Cancer Diagnostics 96%
- A modular toolbox for the optogenetic deactivation of transcription 95%
- New design strategies for ultra-specific CRISPR-Cas13a-based RNA-diagnostic tools with single-nucleotide mismatch sensitivity 95%
Similar papers in this journal
- CRISPR-based multiplex detection of human papillomaviruses for one-pot point-of-care diagnostics 98%
- One-Pot Isothermal Linear Amplification and Cas12a-based Nucleic Acid Detection 96%
- Rapid visual CRISPR assay: a naked-eye colorimetric detection method for nucleic acids based on CRISPR/Cas12a and convolutional neural network 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.